期刊文献+

8-异前列腺F2a、KL-6、SP—D、瘦素在睡眠呼吸暂低通气综合征疾病中的研究进展

The research progress of 8-isoprostane F2a, KL-6, SP-D, leptin in patients with obstructive sleep apnea hypopnea syndrome
原文传递
导出
摘要 8-异前列腺F2a在体内生成结构稳定,不受食物脂质含量的影响,特异性强,能灵敏地反映体内氧化应激水平并与疾病严重程度相关,是评价氧化应激和脂质过氧化反应的理想生物指标。Ⅱ型肺泡细胞表面抗原6(KL-6)、肺表面活性蛋白D(SP—D)主要由肺泡Ⅱ型上皮细胞分泌,夜间慢性间断缺氧及再氧合损伤肺泡屏障、致肺泡部位内皮细胞氧化应激损伤、导致上皮细胞渗透性增高,使KL-6、SP—D浓度升高。肥胖是导致0SAHS的重要危险因素,瘦素是一种由脂肪细胞分泌的重要的抗肥胖激素。现对细胞因子8-异前列腺F2a、KL-6、SP—D、瘦素等生物标记物在OSAHS中的关系做一综述。 8-isoprostane F2a in body can generate a stable structure material which is not affected by dietary lipid content and strong specificity, can sensitively reflect the oxidative stress levels and is correlated with serious degree of disease,is the ideal evaluation biological indicators of oxidative stress and lipid peroxidation. KL-6 and SP-D are mainly secreted by alveolar type II epithelial ceils, at night, chronic intermittent hypoxia and reoxygenation injury alveolar barrier, the oxidative stress injury of endothelial cells in the alveolar region, resulting in increasing permeability of epithelial ceils, increased the concentration of SP-D and KL-6. Obesity is an important risk factor for OSAHS, and leptin is an important anti-obesity hormone secreted by fat cells. In this paper, the relationship between the biological indicators 8-isoprostane F2a,KL-6, SP-D, leptin and OSAHS are reviewed.
出处 《国际呼吸杂志》 2015年第17期1331-1334,共4页 International Journal of Respiration
关键词 8-异前列腺F2a Ⅱ型肺泡细胞表面抗原6 肺表面活性蛋白D 瘦素 阻塞性睡眠呼吸暂 停低通气综合征 8-isoprostane F2al Kerbs. von den lungen-6 Pulmonary surfactant D Leptinl Obstructive sleep apnea hypopnea syndrome
  • 相关文献

参考文献25

  • 1Morrow JD, Roberts LJ 2nd. Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism[J]. Methods Enzymol, 1994,233:163-174.
  • 2Mutze S,Rudnik-SchOneborn S,Zerres K,et al. Genes and the preeclampsia syndrome[J]. J Perinat Med, 2008,36 ( 1 ) : 38- 58.
  • 3林其德.子癎前期及子的病因学研究进展[J].中国实用妇科与产科杂志,2006,22(1):3-5. 被引量:29
  • 4Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress[J]. FASEB J, 2004,18(15) : 1791-1800.
  • 5Pratie6 D, Lawson JA, Rokach J, et al. The isoprostanes in biology and medieine[J]. Trends Endoerinol Metab, 2001,12 (6) :243-247.
  • 6Cooke MS, Evans MD, Dizdaroglu M, et al. Oxidative DNA damage: mechanisms, mutation, and disease [J]. FASEB J, 2003,17(10) : 1195-1214.
  • 7Carpagnano GE, Kharitonov SA, Resta O, et al. 8- Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy[J]. Chest,2003,124(4) :1386-1392.
  • 8Minoguchi K,Yokoe T,Tanaka A,et al. Association between lipid peroxidation and inflammation in obstructive sleep apnoea[J]. Eur Respir J, 2006,28 (2) : 378-385.
  • 9李萍,平芬,韩书芝,牛占丛,苏力.8-异前列腺素F2α与阻塞性睡眠呼吸暂停低通气综合征及其合并高血压的相关性研究[J].中国全科医学,2009,12(15):1387-1389. 被引量:2
  • 10Kuwano K, Maeyama T, Inoshima I, et al. Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases[J]. Respirology, 2002,7 ( 1 ) : 15-21.

二级参考文献22

  • 1林其德.子癎前期子癎病因及发病机制的研究进展[J].中国实用妇科与产科杂志,2004,20(10):577-579. 被引量:71
  • 2刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 3张弘,林其德.pcDNA3-KiSS-1质粒致孕鼠妊娠高血压综合征样病变的实验研究[J].实验动物与比较医学,2005,25(2):77-82. 被引量:3
  • 4林其德.妊高征病因学研究的进展[J].中华妇产科杂志,1997,32(1):3-5. 被引量:126
  • 5[1]Hoffmann M,Bybee K,Accurso V,et al.Sleep apnea and hypertension[J].Minerva Med,2004,95(4):281-290
  • 6[2]Morrow JD.Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans[J].Arterioscler Thromb Vasc Biol,2005,25(2):279-286.
  • 7[6]Montuschi P,Barnes PJ,Roberts LJ.Isoprostanes:markers and mediators of oxidative stress[J].Faseb J,2004,18(15):1791-1800.
  • 8[7]Carpagnano GE,Kharitonov SA,Resta O,et al.8-Isoprostane,a marker of oxidative stress,is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy[J].Chest,2003,124(4):1386-1392.
  • 9[8]Madamanchi NR,VendrovA,Runge MS.Oxidative stress and vascular disease[J].Arterioscler Thromb Vasc Biol,2005,25(1):29-38.
  • 10[9]Lassègue B,Griendling KK.Reactive oxygen species in hypertension:An update[J].Am J Hypertens,2004,17(9):852-860.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部